Unknown

Dataset Information

0

EthA/R-Independent Killing of Mycobacterium tuberculosis by Ethionamide.


ABSTRACT: Ethionamide (ETH) is part of the drug arsenal available to treat multi-drug resistant tuberculosis. The current paradigm of this pro-drug activation involves the mycobacterial enzyme EthA and the transcriptional repressor, EthR. However, several lines of evidence suggest the involvement of additional players. The ethA/R locus was deleted in Mycobacterium bovis BCG and three Mycobacterium tuberculosis (MTB) strains. While complete resistance to ETH was observed with BCG ethA/R KO, drug susceptibility and dose-dependent killing were retained in the ethA/R KO MTB mutants, suggesting the existence of an alternative pathway of ETH bio-activation in MTB. We further demonstrated that this alternative pathway is EthR-independent, whereby re-introduction of ethR in ethA/R KO MTB did not lead to increased resistance to ETH. Consistently, ethA KO MTB (with intact ethR expression) displayed similar ETH susceptibility profile as their ethA/R KO counterparts. To identify the alternative ETH bio-activator, spontaneous ETH-resistant mutants were obtained from ethA/R KO MTB and whole genome sequencing identified single nucleotide polymorphisms in mshA, involved in mycothiol biosynthesis and previously linked to ETH resistance. Deletion of mshA in ethA/R KO MTB led to complete ETH resistance, supporting that the role of MshA in ETH killing is EthA/R-independent. Furthermore mshA single KO MTB displayed levels of ETH resistance similar or greater than those obtained with ethA/R KO strains, supporting that mshA is as critical as ethA/R for ETH killing efficacy.

SUBMITTER: Ang MLT 

PROVIDER: S-EPMC5403819 | biostudies-literature | 2017

REPOSITORIES: biostudies-literature

altmetric image

Publications

EthA/R-Independent Killing of <i>Mycobacterium tuberculosis</i> by Ethionamide.

Ang Michelle L T MLT   Zainul Rahim Siti Z SZ   de Sessions Paola Florez PF   Lin Wenwei W   Koh Vanessa V   Pethe Kevin K   Hibberd Martin L ML   Alonso Sylvie S  

Frontiers in microbiology 20170425


Ethionamide (ETH) is part of the drug arsenal available to treat multi-drug resistant tuberculosis. The current paradigm of this pro-drug activation involves the mycobacterial enzyme EthA and the transcriptional repressor, EthR. However, several lines of evidence suggest the involvement of additional players. The <i>ethA/R</i> locus was deleted in <i>Mycobacterium bovis</i> BCG and three <i>Mycobacterium tuberculosis</i> (MTB) strains. While complete resistance to ETH was observed with BCG <i>et  ...[more]

Similar Datasets

| S-EPMC5700317 | biostudies-literature
| S-SCDT-10_15252-EMBJ_2023113490 | biostudies-other
| S-EPMC16924 | biostudies-literature
| S-EPMC5517500 | biostudies-literature
| S-EPMC2628429 | biostudies-literature
| S-EPMC4649173 | biostudies-literature
| S-EPMC4521081 | biostudies-literature
| S-EPMC8097478 | biostudies-literature
| S-EPMC4328644 | biostudies-literature
| S-EPMC3659392 | biostudies-literature